Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Thermo Fisher Scientific : Expects 2020 Revenue to Grow 20%

10/21/2020 | 10:29am EST

By Dave Sebastian

Thermo Fisher Scientific Inc. executives said the company expects 2020 revenue to grow 20% to about $30.52 billion, its first full-year outlook since it withdrew guidance in April due to Covid-19 uncertainty.

The scientific-equipment and diagnostics company also expects adjusted earnings to rise 48% to $18.27 a share for the year, executives said on a conference call Wednesday.

The estimates are higher than the outlook it put out in late January, when it guided for adjusted earnings of $13.49 to $13.67 a share on revenue of $26.61 billion to $27.01 billion.

The company on Wednesday posted higher-than-expected profit and sales for the September quarter as it benefited from demand for Covid-19 testing.

For the fourth quarter, the company expects organic growth of 29%, with an expected $1.75 billion in Covid-19 response revenue and organic growth in the base business of low- to mid-single digits, Finance Chief Stephen Williamson said.

The company expects fourth-quarter adjusted earnings to grow about 60% from the same quarter last year, Mr. Williamson said. He added that the outlook doesn't anticipate the kind of lockdowns seen earlier this year amid the pandemic.

Shares rose 2.4% to $476.50.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

10-21-20 1028ET

All news about THERMO FISHER SCIENTIFIC
12:47pTHERMO FISHER SCIENTIFIC INC. : Regulation FD Disclosure (form 8-K)
AQ
09:20aTHERMO FISHER SCIENTIFIC : to Present at the Evercore ISI HealthCONx Conference ..
AQ
11/30THERMO FISHER SCIENTIFIC : to Present at the Evercore ISI HealthCONx Conference ..
PR
11/24Ford orders 12 ultra-cold freezers to distribute COVID-19 vaccines to employe..
RE
11/20THERMO FISHER SCIENTIFIC INC. : Change in Directors or Principal Officers (form ..
AQ
11/20THERMO FISHER SCIENTIFIC : Elects New Director to Board
PR
11/19THERMO FISHER SCIENTIFIC : Scientific Tundra Cryo-TEM Democratizes Cryo-Electron..
AQ
11/11THERMO FISHER SCIENTIFIC : Scientific Axia ChemiSEM Increases Data Acquisition S..
AQ
11/10Oxford ups COVID-19 testing capacity with Thermo Fisher deal
RE
11/09THERMO FISHER SCIENTIFIC : and Innoforce Partner to Establish Biologics and Ster..
AQ
More news
Financials (USD)
Sales 2020 30 776 M - -
Net income 2020 5 934 M - -
Net Debt 2020 11 881 M - -
P/E ratio 2020 31,5x
Yield 2020 0,19%
Capitalization 187 B 187 B -
EV / Sales 2020 6,45x
EV / Sales 2021 5,83x
Nbr of Employees 75 000
Free-Float 90,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Average target price 508,80 $
Last Close Price 471,10 $
Spread / Highest target 23,1%
Spread / Average Target 8,00%
Spread / Lowest Target -18,5%
EPS Revisions
Managers
NameTitle
Marc N. Casper Chairman, President & Chief Executive Officer
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Scott M. Sperling Independent Director
Sector and Competitors